HealthAlleyWatchabout 1 hour ago
Biotia Raises $9M to Advance UTI Diagnostics
8 min read
Biotia, a diagnostics company spun out of Cornell Tech, secured $9 million in extension financing to advance its clinical metagenomics platform. The company targets recurrent and culture-negative UTIs with its BIOTIA-ID Urine Test, offering pathogen-specific answers in 2 to 3 days.
Level
Hype check
Tap to vote and see what everyone thinks.
